Mackenzie Financial Corp Has $207.69 Million Stock Position in Maximus, Inc. (NYSE:MMS)

Mackenzie Financial Corp lifted its position in Maximus, Inc. (NYSE:MMS - Free Report) by 2.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 2,782,150 shares of the health services provider's stock after acquiring an additional 55,583 shares during the period. Mackenzie Financial Corp owned about 4.92% of Maximus worth $207,687,000 as of its most recent SEC filing.

Other institutional investors have also made changes to their positions in the company. UMB Bank n.a. raised its holdings in Maximus by 79.8% during the fourth quarter. UMB Bank n.a. now owns 356 shares of the health services provider's stock valued at $27,000 after buying an additional 158 shares in the last quarter. V Square Quantitative Management LLC boosted its holdings in shares of Maximus by 65.9% during the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider's stock worth $34,000 after buying an additional 180 shares during the period. R Squared Ltd bought a new position in shares of Maximus in the fourth quarter worth about $54,000. IFP Advisors Inc increased its stake in shares of Maximus by 62.4% in the fourth quarter. IFP Advisors Inc now owns 786 shares of the health services provider's stock worth $59,000 after purchasing an additional 302 shares during the period. Finally, Farther Finance Advisors LLC increased its stake in shares of Maximus by 109.2% in the fourth quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider's stock worth $61,000 after purchasing an additional 428 shares during the period. 97.21% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen lowered Maximus from a "buy" rating to a "hold" rating in a research note on Thursday, May 15th.

Maximus Price Performance

NYSE MMS traded down $0.84 during trading on Thursday, reaching $71.80. 182,343 shares of the company traded hands, compared to its average volume of 606,192. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.72 and a current ratio of 1.72. The stock's 50 day moving average price is $69.70 and its two-hundred day moving average price is $71.94. The company has a market cap of $4.05 billion, a price-to-earnings ratio of 15.44 and a beta of 0.61. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97.

Maximus (NYSE:MMS - Get Free Report) last released its quarterly earnings results on Thursday, May 8th. The health services provider reported $2.01 EPS for the quarter, topping analysts' consensus estimates of $1.37 by $0.64. The business had revenue of $1.36 billion for the quarter, compared to analyst estimates of $1.29 billion. Maximus had a return on equity of 21.95% and a net margin of 5.28%. Maximus's revenue for the quarter was up 1.0% on a year-over-year basis. During the same period in the prior year, the company earned $1.57 EPS. As a group, analysts anticipate that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Shareholders of record on Thursday, May 15th will be given a $0.30 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.67%. Maximus's payout ratio is 23.86%.

Insider Buying and Selling at Maximus

In other news, Director Jan Madsen sold 2,439 shares of the stock in a transaction on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the transaction, the director now owns 18,097 shares of the company's stock, valued at $1,225,347.87. This represents a 11.88% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 1.60% of the company's stock.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.